Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	May 01, 2021	Jan. 30, 2021	Aug. 01, 2020	May 02, 2020
Operating activities
Net earnings	$ 2,097	$ 1,380	$ 1,690	$ 284
Adjustments to reconcile net earnings to cash provided by operating activities:
Depreciation and amortization	667			641
Share-based compensation expense	79			49
Deferred income taxes	170			(4)
Gain on Dermstore sale	(335)			0
Noncash losses / (gains) and other, net	(30)			5
Changes in operating accounts:
Inventory	114			408
Other assets	(5)			11
Accounts payable	(1,205)			(280)
Accrued and other liabilities	(413)			170
Cash provided by operating activities	1,139			1,284
Investing activities
Expenditures for property and equipment	(540)			(751)
Proceeds from disposal of property and equipment	12			6
Proceeds from Dermstore sale	356			0
Other investments	7			1
Cash required for investing activities	(165)			(744)
Financing activities
Additions to long-term debt	0			2,480
Reductions of long-term debt	(21)			(17)
Dividends paid	(340)			(332)
Repurchase of stock	(1,310)			(686)
Stock option exercises	2			4
Cash (required for) / provided by financing activities	(1,669)			1,449
Net (decrease) / increase in cash and cash equivalents	(695)			1,989
Cash and cash equivalents at beginning of period	8,511		$ 4,566	2,577
Cash and cash equivalents at end of period	7,816	$ 8,511		4,566
Supplemental information
Leased assets obtained in exchange for new finance lease liabilities	69			103
Leased assets obtained in exchange for new operating lease liabilities	$ 189			$ 97